Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

Results 1-10 of 32
Item hits:
Issue DateTitleAuthor(s)
Nov-2020The structure-function relationship of oncogenic LMTK3.Ditsiou, A; Cilibrasi, C; Simigdala, N; Papakyriakou, A; Milton-Harris, L, et al
Jan-2021Characterization of the cytokine storm reflects hyperinflammatory endothelial dysfunction in COVID-19Sims, JT; Krishnan, V; Chang, C-Y; Eagle, SM; Casalini, G, et al
12-Mar-2021Point-of-care SARS-CoV-2 serological assays for enhanced case finding in a UK inpatient population.Pallett, SJC; Denny, S; Patel, A; Charani, E; Mughal, N, et al
1-Jul-2021Circulating microRNAs in small-bowel neuroendocrine tumors: a potential tool for diagnosis and assessment of effectiveness of surgical resectionMalczewska, A; Frampton, AE; Mato Prado, M; Ameri, S; Dabrowska, AF, et al
14-Jun-2021EGFR-mutated squamous cell lung cancer and its association with outcomesJin, R; Peng, L; Shou, J; Wang, J; Jin, Y, et al
1-Jan-2021JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortalityStebbing, J; Nievas, GS; Falcone, M; Youhanna, S; Richardson, P, et al
4-Feb-2021What is the intermediate host species of SARS-CoV-2?Friend, T; Stebbing, J;
18-Dec-2020What is the best drug to treat COVID-19? The need for randomized controlled trialsOttaviani, S; Stebbing, J;
17-Mar-2021LMTK3 inhibition affects microtubule stabilityCilibrasi, C; Ditsiou, A; Papakyriakou, A; Mavridis, G; Eravci, M, et al
17-Nov-2020Repurposing fostamatinib to combat SARS-CoV-2-induced acute lung injury.Tabassum, N; Zhang, H; Stebbing, J;